HCA Healthcare (NYSE:HCA – Get Free Report) was downgraded by stock analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued on Friday. HCA has been the topic of a number of other research reports. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $335.00 target price on shares […]